These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 22179033)

  • 1. Combined use of high-sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure.
    Bayes-Genis A; de Antonio M; Galán A; Sanz H; Urrutia A; Cabanes R; Cano L; González B; Díez C; Pascual T; Elosúa R; Lupón J
    Eur J Heart Fail; 2012 Jan; 14(1):32-8. PubMed ID: 22179033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment.
    Lupón J; de Antonio M; Galán A; Vila J; Zamora E; Urrutia A; Bayes-Genis A
    Mayo Clin Proc; 2013 Mar; 88(3):234-43. PubMed ID: 23384388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
    Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of diabetes on the predictive value of heart failure biomarkers.
    Alonso N; Lupón J; Barallat J; de Antonio M; Domingo M; Zamora E; Moliner P; Galán A; Santesmases J; Pastor C; Mauricio D; Bayes-Genis A
    Cardiovasc Diabetol; 2016 Nov; 15(1):151. PubMed ID: 27809845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTproBNP and ST2 as predictors for all-cause and cardiovascular mortality in elderly patients with symptoms suggestive for heart failure.
    Boman K; Thormark Fröst F; Bergman AR; Olofsson M
    Biomarkers; 2018; 23(4):373-379. PubMed ID: 29355441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure.
    Rehman SU; Mueller T; Januzzi JL
    J Am Coll Cardiol; 2008 Oct; 52(18):1458-65. PubMed ID: 19017513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ST2 pathogenetic profile in ambulatory heart failure patients.
    Bayes-Genis A; Januzzi JL; Gaggin HK; de Antonio M; Motiwala SR; Zamora E; Galán A; Domingo M; Urrutia A; Lupón J
    J Card Fail; 2015 Apr; 21(4):355-61. PubMed ID: 25451702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimarker Strategy for Heart Failure Prognostication. Value of Neurohormonal Biomarkers: Neprilysin vs NT-proBNP.
    Bayes-Genis A; Barallat J; Galán A; de Antonio M; Domingo M; Zamora E; Gastelurrutia P; Vila J; Peñafiel J; Gálvez-Montón C; Lupón J
    Rev Esp Cardiol (Engl Ed); 2015 Dec; 68(12):1075-84. PubMed ID: 26297179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure.
    Pascual-Figal DA; Manzano-Fernández S; Boronat M; Casas T; Garrido IP; Bonaque JC; Pastor-Perez F; Valdés M; Januzzi JL
    Eur J Heart Fail; 2011 Jul; 13(7):718-25. PubMed ID: 21551163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure.
    Ahmad T; Fiuzat M; Neely B; Neely ML; Pencina MJ; Kraus WE; Zannad F; Whellan DJ; Donahue MP; Piña IL; Adams KF; Kitzman DW; O'Connor CM; Felker GM
    JACC Heart Fail; 2014 Jun; 2(3):260-8. PubMed ID: 24952693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure.
    Gaggin HK; Szymonifka J; Bhardwaj A; Belcher A; De Berardinis B; Motiwala S; Wang TJ; Januzzi JL
    JACC Heart Fail; 2014 Feb; 2(1):65-72. PubMed ID: 24622120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined use of high-sensitivity ST2 and NT-proBNP for predicting major adverse cardiovascular events in coronary heart failure.
    Bai J; Han L; Liu H
    Ann Palliat Med; 2020 Jul; 9(4):1976-1989. PubMed ID: 32762223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.
    Zethelius B; Berglund L; Sundström J; Ingelsson E; Basu S; Larsson A; Venge P; Arnlöv J
    N Engl J Med; 2008 May; 358(20):2107-16. PubMed ID: 18480203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incremental prognostic and clinical value of multiple novel biomarkers in heart failure.
    Jackson CE; Haig C; Welsh P; Dalzell JR; Tsorlalis IK; McConnachie A; Preiss D; Anker SD; Sattar N; Petrie MC; Gardner RS; McMurray JJ
    Eur J Heart Fail; 2016 Dec; 18(12):1491-1498. PubMed ID: 27114189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
    Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F
    Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure.
    Tang WH; Wu Y; Grodin JL; Hsu AP; Hernandez AF; Butler J; Metra M; Voors AA; Felker GM; Troughton RW; Mills RM; McMurray JJ; Armstrong PW; O'Connor CM; Starling RC
    JACC Heart Fail; 2016 Jan; 4(1):68-77. PubMed ID: 26656144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure.
    Ky B; French B; McCloskey K; Rame JE; McIntosh E; Shahi P; Dries DL; Tang WH; Wu AH; Fang JC; Boxer R; Sweitzer NK; Levy WC; Goldberg LR; Jessup M; Cappola TP
    Circ Heart Fail; 2011 Mar; 4(2):180-7. PubMed ID: 21178018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The real-life value of ST2 monitoring during heart failure decompensation: impact on long-term readmission and mortality.
    Llibre C; Zamora E; Caballero À; Lupón J; Ros A; Benito N; de Antonio M; Galán A; Domingo M; Bayes-Genis A
    Biomarkers; 2016; 21(3):225-32. PubMed ID: 26767401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ST2 may not be a useful predictor for incident cardiovascular events, heart failure and mortality.
    Hughes MF; Appelbaum S; Havulinna AS; Jagodzinski A; Zeller T; Kee F; Blankenberg S; Salomaa V;
    Heart; 2014 Nov; 100(21):1715-21. PubMed ID: 25080471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.